Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
inqbio.com

See what CB Insights has to offer

Total Raised

$6.07M

Investors Count

5

Deal Terms

4

InQ Biosciences Funding, InQ Biosciences Valuation & InQ Biosciences Revenue

6 Fundings

InQ Biosciences's latest funding round was a Angel - V for $0.87M on September 1, 2012.

InQ Biosciences's valuation in March 2012 was $6.55M.

InQ Biosciences's latest post-money valuation is from September 2012.

Sign up for a free trial to see InQ Biosciences's valuations in September 2012, December 2011 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

9/1/2012

Angel - V

$0.87M

$99M

3/19/2012

Angel - IV

$99M

$6.55M

0

12/23/2011

Angel - III

$99M

$99M

0

3/12/2011

Angel - II

$99M

0

7/16/2010

Unattributed VC

$99M

0

Date

9/1/2012

3/19/2012

12/23/2011

3/12/2011

7/16/2010

Round

Angel - V

Angel - IV

Angel - III

Angel - II

Unattributed VC

Amount

$0.87M

$99M

$99M

$99M

$99M

Investors

Valuation

$99M

$6.55M

$99M

Revenue

Sources

0

0

0

0

InQ Biosciences Deal Terms

4 Deal Terms

InQ Biosciences's deal structure is available for 4 funding rounds, including their Angel - V from September 01, 2012.

Round

Angel - V

Angel - IV

Angel - III

Angel

Funding Date

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Angel - V

$99M

$99M

$99M

$99M

$99M

$99M

Angel - IV

$99M

$99M

$99M

$99M

$99M

$99M

Angel - III

$99M

$99M

$99M

$99M

$99M

$99M

Angel

$99M

$99M

$99M

$99M

$99M

$99M

InQ Biosciences Investors

5 Investors

InQ Biosciences has 5 investors. Huntsville Angel Network invested in InQ Biosciences's Angel - V funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

7/11/2008

9/1/2012

6
Unattributed VC, Angel (2008), Angel - III (2011), Angel - II (2011), Angel - IV (2012), Angel - V (2012)

Angel Investor (Group)

Alabama

00/00/0000

00/00/0000

Angel Investor Management Group

Subscribe to see more

Angel Investor (Group)

Alabama

00/00/0000

00/00/0000

Auburn Angel Network

Subscribe to see more

Angel Investor (Group)

00/00/0000

00/00/0000

Business Technology Development Center

Subscribe to see more

Angel Investor (Group)

Alabama

00/00/0000

00/00/0000

Angel Capital Group

Subscribe to see more

Angel Investor (Group)

Tennessee

First funding

7/11/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

9/1/2012

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Angel Investor Management Group

Auburn Angel Network

Business Technology Development Center

Angel Capital Group

Rounds

6
Unattributed VC, Angel (2008), Angel - III (2011), Angel - II (2011), Angel - IV (2012), Angel - V (2012)

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Type

Angel Investor (Group)

Angel Investor (Group)

Angel Investor (Group)

Angel Investor (Group)

Angel Investor (Group)

Location

Alabama

Alabama

Alabama

Tennessee

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.